Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

TGCS's Annual Meeting, August 10-12, 2012

Thanapprapasr D, Wilailak S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Journal correction: Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement

No authors listed

In this published article by Lee et al., the abstract was the incomplete one before revision. The editorial board of Journal of Gynecologic Oncology would like to correct the abstract...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?

Gaffney DK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Book Review: The emperor of all maladies: a biography of cancer

Suh DH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emerging concept of tailored lymphadenectomy in endometrial cancer

Sakuragi N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combat against cervical cancer-challenges in Asia Oceania: 5th Biennial Conference of the Asia Oceania Research Organization on Genital Infections & Neoplasia (AOGIN)

Ngan HY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sweet's syndrome: a cutaneous harbinger of ovarian carcinoma

Fader AN, Winder AD, Sandadi S, DeBernardo R

Sweet's syndrome, or acute febrile neutrophilic dermatosis, is a condition characterized by fever, neutrophilia, erythematous skin lesions, and a dermal infiltrate consisting predominantly of mature neutrophils on histology. Sweet's syndrome...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New insights into cervical cancer screening

Boone JD, Erickson B, Huh WK

Worldwide, cervical cancer is a leading cause of cancer related morbidity and mortality. For over 50 years, cervical cytology has been the gold standard for cervical cancer screening. Because of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma

Bahng AY, Chu C, Wileyto P, Rubin S, Lin LL

OBJECTIVE: To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma. METHODS: A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study

Kang S, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Park SY, Park CY, Kim KT

OBJECTIVE: The aim of this study was to identify a standard for the evaluation of future models for prediction of lymph node metastasis in endometrial cancer through estimation of performance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer

Kong TW, Chang SJ, Paek J, Yoo SC, Yoon JH, Chang KH, Chun M, Ryu HS

OBJECTIVE: Concurrent chemoradiation therapy (CCRT) is the standard treatment for locally advanced cervical cancer. Although the optimal chemotherapeutic regimen is not yet defined, previous randomized trials have demonstrated that 5-fluorouracil...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer

Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Kim YS, Kim HJ, Lee JW, Kim BG, Bae DS, Huh SJ, Nam JH

OBJECTIVE: To compare survival outcomes and treatment-related morbidities between radical hysterectomy (RH) and primary chemoradiation therapy (CRT) in patients with bulky early-stage cervical cancer. METHODS: We selected 215 patients with stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea

Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY

OBJECTIVE: To evaluate survival and morbidity after pelvic exenteration (PE) for the curative management of recurrent cervical cancer. METHODS: We retrospectively evaluated patients with recurrent cervical cancer who underwent PE from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer

Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T

OBJECTIVE: To determine whether preoperative platelets to lymphocyte ratio (PLR) could predict disease stage, surgical outcome, and survival in patients with epithelial ovarian cancer (EOC). METHODS: Medical records of EOC patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Early human papillomavirus testing predicts residual/recurrent disease after LEEP

Ryu A, Nam K, Kwak J, Kim J, Jeon S

OBJECTIVE: The purpose of this study was to determine the predictive factors for residual/recurrent disease and to analyze the timing for Pap smears and human papillomavirus (HPV) testing during follow-up...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration

Oh HK, Sin JI, Choi J, Park SH, Lee TS, Choi YS

OBJECTIVE: The purpose of the current study was to evaluate survival outcome according to the expression status of CD73 in patients with epithelial ovarian cancer. METHODS: A total of 167 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr